American Diabetes Association, Early Cognitive Function Evaluation: A Tool to Improve Quality of Care
“Poor glycemic control is associated with a decline in cognitive function. The presence of cognitive impairment can make it challenging for clinicians to help their patients reach individual glycemic, blood pressure, and lipid targets.”
ADA Recommendations:
– Screening for early detection of mild cognitive impairment or dementia and depression is indicated for adults 65 years of age or older at the initial visit and annually as appropriate.
– Screening for cognitive impairment should additionally be considered in the presence of a significant decline in clinical status.